Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by C. Slader
Chronic Phase Chronic Myeloid Leukemia Patients With Low OCT-1 Activity Randomized to High-Dose Imatinib Achieve Better Responses and Have Lower Failure Rates Than Those Randomized to Standard-Dose Imatinib
Haematologica
Hematology
Related publications
Result of High-Dose Imatinib Mesylate in Patients With Philadelphia Chromosome--Positive Chronic Myeloid Leukemia After Failure of Interferon-
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Micro-Rna Response to Imatinib Mesylate in Patients With Chronic Myeloid Leukemia
Haematologica
Hematology
Suboptimal Responses to Imatinib in Chronic Myelogenous Leukemia
Clinical Journal of Oncology Nursing
Oncology
Pancreatic Enzyme Elevation in Chronic Myeloid Leukemia Patients Treated With Nilotinib After Imatinib Failure
Haematologica
Hematology
Therapeutic Drug Monitoring of Imatinib for Chronic Myeloid Leukemia Patients
Imatinib and Plasmacytoid Dendritic Cell Function in Patients With Chronic Myeloid Leukemia
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Long-Term Molecular Responses to Imatinib in Patients With Chronic Myeloid Leukemia: Comparison Between Complete Cytogenetic Responders Treated in Early and in Late Chronic Phase
Haematologica
Hematology
Functional Activity of Cd34-Positive Cells in Chronic Myeloid Leukemia Patients With Different Response to Imatinib Therapy
Experimental Oncology
Cancer Research
Oncology
Polycomb Genes Are Associated With Response to Imatinib in Chronic Myeloid Leukemia
Epigenomics
Cancer Research
Genetics
